February 2012
SUANFARMA BIOTECH SEGCR prepares the output to MAB of its investee PEVESA

PEVESA is a consolidated andalusian biotech company based on patented proprietary technologies. This company creates employment, exports, and generates wealth. Its business plan considers an aggressive growth plan for the coming years.

According to the production plan for 2012, the current manufacturing facilities will reach its production ceiling this exercise. Therefore, PEVESA must undertake an investment of around EUR 3 million, which will allow to double production capacity and employees.

In order to obtain the necessary financing for enlargement of its manufacturing facilities, PEVESA´s partners have decided to undertake the entry of the company in the Alternative Investment Market so it can raise capital to carry on with the investments as well as ensure the financing of the high growth rates expected in the coming years.

PEVESA would be the first company manufacturer of food products to enter the MAB.